patent/EP-0278715-A2

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-217
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate	1988-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bea1e6bb97f3acf701544fa2cbc44dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df2bf1b081a12c1bbd19ca97c918ce69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbbbb04a6d92283b8d578670666602c3
publicationDate	1988-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-0278715-A2
titleOfInvention	Use of human gamma interferon for treatment of basal cell carcinoma
abstract	The use of human gamma interferon in treating basal cell carcinoma is described.
priorityDate	1987-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0248583-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8705518-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0177910-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8301198-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0077063-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0048283-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4460574-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360437 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408144271 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408271913 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11192 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409045

Total number of triples: 29.